Intorduction: Abnormal bone metabolism in patients with thyrotoxicosis is well documented, but time-course of recovery remains poorly understood. Objective: To evaluate changes in bone density and bone metabolic parameters in thyrotoxicosis before and after therapy. Methods: Forty patients with thyrotoxicosis (11 males; mean age 35.5 ± 9.9 years) rendered euthyroid with methimazole and maintained on block-replacement therapy were followed up for six months at a tertiary care setting. Of these, 21 had completed follow-up evaluation. Bone mineral density (BMD) at lumbar spine (LS), hip and biochemical markers were estimated before and after therapy. Results: At LS, 21% women and 35% men had a Z score less than -2. At the neck of femur (NOF),17% women and 18% men had Z score less than -2. LS was more severely affected (p < 0.001). BMD was similar among patients who were 25hydroxy vitamin D [25(OH)D] deficient,[25(OH)D < 20 ng/mL (<50 nmol/L)], insufficient [25(OH)D 20 -30 ng/mL (50-75 nmol/L)] or sufficient [25(OH)D > 30 ng/mL (>50 nmol/L)]. Serum T 4 correlated negatively with Z-scores at LS, NOF, trochanter and Ward's area. There was improvement in BMD (p<0.01) and Z scores (p<0.01) at all levels post-treatment with higher increase at NOF (p=0.046). A significant decrease in serum calcium, 24 hour urinary calcium and phosphate and the fractional excretions of calcium and phosphate was also seen, while serum N-tact PTH levels increased. Conclusions: Correction of hyperthyroidism plays a pivotal role in improving the BMD and biochemical parameters. Amaresh Reddy P, Harinarayan CV, Suresh V, Rajagopal G, Krishna Tilak T, Suchitra MM, Srinivasa Rao PVLN, Sachan A. Effect of block-replacement regimen on bone mineral density and biochemical markers in patients with thyrotoxic bone diseaseJ Clin Sci Res 2012;1:60-9.
Effects of block-replacement regimen on thyrotoxic bone diseaseAmaresh Reddy et al